Condition : Arthritis, Psoriatic Interventions : Drug: Placebo; Drug: Ustekinumab 45 mg; Drug: Utekinumab 90 mg Sponsors : Janssen Research & Development, LLC; Janssen Research & Development, LLC Comp...

This study is designed to evaluate the safety and efficacy of a dose and dosage regimen of SBI-087 in seropositive patients with active Rheumatoid Arthritis, who are on a stable dose of methotrexate.

Conditions : Degenerative Joint Disease; Avascular Necrosis Interventions : Device: Metal-on-Metal Articulation; Device: Metal-on-Metal Acetabular System Sponsors : Biomet, Inc.; Biomet Japan, Inc. Re...

This study is designed to evaluate the safety and efficacy of a dose and dosage regimen of SBI-087 in seropositive patients with active Rheumatoid Arthritis, who are on a stable dose of methotrexate.

Condition : Rheumatoid Arthritis Interventions : Biological: ATN-103 10 mg q4wks; Biological: ATN-103 30 mg q4wks; Biological: ATN-103 80 mg q4wks; Biological: ATN-103 10 mg q8wks; Biological: ATN-103...

Conditions : Arthritis; Arthritis, Rheumatoid; Autoimmune Diseases Interventions : Drug: golimumab or placebo; Drug: golimumab; Drug: golimumab or placebo; Drug: golimumab; Drug: golimumab or placebo...

Conditions : Arthritis; Arthritis, Rheumatoid; Autoimmune Diseases Interventions : Drug: golimumab or placebo; Drug: golimumab; Drug: golimumab or placebo Sponsors : Centocor, Inc.; Schering-Plough Re...

The purpose of this study is to assess the efficacy of abatacept after subcutaneous administration and intravenous administration in Japanese active rheumatoid arthritis (RA) subjects with inadequate...

The purpose of this study is to assess the efficacy of abatacept after subcutaneous administration and intravenous administration in Japanese active rheumatoid arthritis (RA) subjects with inadequate...

Condition : Rheumatoid Arthritis Intervention : Other: non interventional Sponsor : Pfizer Active, not recruiting - verified August 2011